| Acute hepatitis C treatment in advanced renal failure using 8 weeks of pan-genotypic daclatasvir and reduced-dose sofosbuvir A Goel, DS Bhadauria, A Kaul, A Verma, P Tiwari, S Rungta, P Rai, ... Nephrology Dialysis Transplantation 36 (10), 1867-1871, 2021 | 9 | 2021 |
| Serological Immune Response Following ChAdOx1 nCoV-19 Vaccine (Covishield®) in Patients with Liver Cirrhosis A Goel, A Verma, P Tiwari, H Katiyar, A Aggarwal, D Khetan, RVK Kishore, ... Vaccines 10 (11), 1837, 2022 | 6 | 2022 |
| Antibody Response to ChAdOx1 nCoV-19 (AZD1222) Vaccine in Kidney Transplant Recipients DS Bhadauria, H Katiyar, A Goel, P Tiwari, RVK Kishore, A Aggarwal, ... Vaccines 10 (10), 1693, 2022 | 6 | 2022 |
| Use of Sofosbuvir/Velpatasvir/Voxilaprevir for Sofosbuvir Nonresponder Genotype 3 HCV Infection in India P Tiwari, H Katiyar, P Rai, A Goel Journal of Clinical and Experimental Hepatology 12 (2), 669-671, 2022 | 3 | 2022 |
| Liver Stiffness is Reduced to Normal After Successful Renal Transplantation: A Prospective Cohort Study DS Bhadauria, P Kumar, P Tiwari, A Kaul, TS Negi, P Rai, S Shanmugam, ... Journal of Clinical and Experimental Hepatology 12 (6), 1445-1450, 2022 | 2 | 2022 |
| Serological immune response following ChAdOx1 nCoV-19 vaccine (Covishield) in patients with liver cirrhosis H Katiyar, A Goel, P Tiwari, A Aggarwal, A Verma, D Khetan, M Rajput, ... Journal of Clinical and Experimental Hepatology 12, S44-S45, 2022 | | 2022 |
| Hepatitis C re-treatment with first line direct acting antiviral drugs P Tiwari, H Katiyar, S Rungta, A Verma, A Deep, P Rai, R Aggarwal, ... Journal of Clinical and Experimental Hepatology 12, S88, 2022 | | 2022 |
